Zynyz

retifanlimab-dlwr

Approval

ApplicationBLA 761334
Approval dateMar 22, 2023
Approval year2023
SponsorIncyte CORP

FDA-approved use

To treat metastatic or recurrent locally advanced Merkel cell carcinoma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Zynyz: